Question 1

How many shares of SAVA does UBS Group AG own?

Accepted Answer

As of 2026-Q2, UBS Group AG holds 39,062 shares of SAVA (FILANA THERAPEUTICS INC).

Question 2

What is UBS Group AG's SAVA position worth?

Accepted Answer

As of 2026-Q2, UBS Group AG's SAVA position is worth $46,484.

Question 3

Is UBS Group AG buying or selling SAVA?

Accepted Answer

In 2026-Q2, UBS Group AG increased their SAVA position (+236.7% change in shares).

Question 4

When did UBS Group AG first buy SAVA?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in SAVA in 2024-Q3. They have held the position across 30 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	39,062	+236.7%	$46,484	0.0%	$2.22	22
2026-Q1	Decreased	11,603	-61.1%	$19,609	0.0%	$2.22	0
2025-Q4	Decreased	29,869	-84.2%	$59,140	0.0%	$2.03	0
2025-Q3	Decreased	188,993	-0.6%	$549,970	0.0%	$3.14	0
2025-Q2	Decreased	190,085	-65.2%	$344,054	0.0%	$1.75	0
2025-Q1	Decreased	545,815	-41.4%	$818,723	0.0%	$1.65	0
2024-Q4	Increased	930,726	+947.3%	$2.2M	0.0%	$2.40	42
2024-Q3	Increased	88,873	+41.0%	$2.6M	0.0%	$28.49	35